·Confidence 90%
Dow Futures Decline Due to Swiss Drug Company's Setback
Dow futures are underperforming the S&P 500 following a late-stage setback for a cardiovascular drug from a Swiss company, impacting market sentiment.
2 articles tagged with #pharmaceuticals
Dow futures are underperforming the S&P 500 following a late-stage setback for a cardiovascular drug from a Swiss company, impacting market sentiment.
Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and